Biblio

Dupont B, Mariotte D, Dugue AE, Clarisse B, Grellard J-M, Babin E, Chauffert B, Dakpe S, Moldovan C, Bouhier-Leporrier K et al..  2017.  Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 83:623-631.

Grimaldi-Bensouda L, Abenhaim L, Massol J, Guillemot D, Avouac B, Duru G, Lert F, Magnier A-M, Rossignol M, Rouillon F et al..  2015.  Utilization of psychotropic drugs by patients consulting for sleeping disorders in homeopathic and conventional primary care settings: the EPI3 cohort study. HOMEOPATHY. 104:170-175.

Candelier K., Hannouz S., Elaieb M., Collet R., Dumarcay S., Petrissans A., Gerardin P., Petrissans M..  2015.  UTILIZATION OF TEMPERATURE KINETICS AS A METHOD TO PREDICT TREATMENT INTENSITY AND CORRESPONDING TREATED WOOD QUALITY: DURABILITY AND MECHANICAL PROPERTIES OF THERMALLY MODIFIED WOOD. MADERAS-CIENCIA Y TECNOLOGIA. 17:253-262.

Chaufray J-Y, Lamy L, Rousselot P, Barthelemy M.  Submitted.  UV exploration of the solar system. EXPERIMENTAL ASTRONOMY.

Pfendler S, Einhorn O, Bousta F, Khatyr A, Alaoui-Sosse L, Aleya L, Alaoui-Sosse B.  2017.  UV-C as a means to combat biofilm proliferation on prehistoric paintings: evidence from laboratory experiments. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH. 24:21601-21609.

Pfendler S, Einhorn O, Karimi B, Bousta F, Cailhol D, Alaoui-Sosse L, Alaoui-Sosse B, Aleya L.  2017.  UV-C as an efficient means to combat biofilm formation in show caves: evidence from the La Glaciere Cave (France) and laboratory experiments. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH. 24:24611-24623.

Seve P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, Bielefeld P, Sene D, Kaplanski G, Monnet D et al..  2017.  Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. AUTOIMMUNITY REVIEWS. 16:1254-1264.

Seve P., Bodaghi B., Trad S., Sellam J., Bellocq D., Bielefeld P., Sene D., Kaplanski G., Monnet D., Brezin A. et al..  2018.  Uveitis: Diagnostic work-up. Recommendations from an expert committee. REVUE DE MEDECINE INTERNE. 39:676-686.

Saadoun D., Trad S., Bielfeld P., Sene D., Abad S., Kaplanski G., Terrada C., Kodjikian L., Bodaghi B., Seve P..  2018.  Uveitis: From diagnosis to treatment. REVUE DE MEDECINE INTERNE. 39:673-675.

Wendling D, Prati C, Lequerre T, Miceli C, Dougados M, Molto A, Guillot X.  2021.  Uveitis occurrence in early inflammatory back pain. Five years data from the prospective French nationwide DESIR cohort. JOINT BONE SPINE. 88:105100.

Wendling D, Prati C, Lequerre T, Miceli-Richard C, Dougados M, Molto A, Guillot X.  2020.  Uveitis Occurrence in Early Inflammatory Back Pain: Five Years Data from a Prospective French Nationwide Cohort. ARTHRITIS & RHEUMATOLOGY. 72

Wendling D., Prati C., Lequerre T., C. Richard M, Dougados M., Molto A., Guillot X..  2020.  UVEITIS OCCURRENCE IN EARLY INFLAMMATORY BACK PAIN. FIVE YEARS DATA FROM A PROSPECTIVE FRENCH NATIONWIDE COHORT. ANNALS OF THE RHEUMATIC DISEASES. 79:750-751.

Wendling D, Prati C, Lequerre T, Miceli-Richard C, Dougados M, Molto A, Guillot X.  2020.  Uveitis Occurrence in Early Inflammatory Back Pain: Five Years Data from a Prospective French Nationwide Cohort. ARTHRITIS & RHEUMATOLOGY. 72

Wendling D., Prati C., Lequerre T., Miceli-Richard C., Dougados M., Molto A., Guillot X..  2021.  UVEITIS OCCURRENCE IN EARLY INFLAMMATORY BACK PAIN - FIVE YEARS DATA FROM THE PROSPECTIVE FRENCH NATIONWIDE COHORT DESIR. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 39:1181.

Perret S., Ghosh A.N, Fanjoux G., Provino L., Taunay T., Monteville A., Landais D., Dudley J.M, Sylvestre T..  2019.  UV-Grade Silica-based Photonic Crystal Fibers for broadband UV generation over 350-395 nm. 2019 CONFERENCE ON LASERS AND ELECTRO-OPTICS EUROPE & EUROPEAN QUANTUM ELECTRONICS CONFERENCE (CLEO/EUROPE-EQEC).

Clos P, Laroche D, Pageaux B.  2018.  (V) over dotO(2PEAK) IS OF GREAT INTEREST FOR CLINICAL PURPOSES. JOURNAL OF APPLIED PHYSIOLOGY. 125:238.

Clos P, Laroche D, Pageaux B.  2018.  (V) over dotO(2PEAK) IS OF GREAT INTEREST FOR CLINICAL PURPOSES. JOURNAL OF APPLIED PHYSIOLOGY. 125:238.

Lombard A, Abbas-Turki A, Moudni AEl.  2020.  V2V-Based Memetic Optimization for Improving Traffic Efficiency on Multi-Lane Roads. IEEE INTELLIGENT TRANSPORTATION SYSTEMS MAGAZINE. 12:35-46.

Du W, Abbas-Turki A, Koukam A, Galland S, Gechter F.  2018.  On the V2X speed synchronization at intersections: Rule based System for extended virtual platooning. 9TH INTERNATIONAL CONFERENCE ON EMERGING UBIQUITOUS SYSTEMS AND PERVASIVE NETWORKS (EUSPN-2018) / 8TH INTERNATIONAL CONFERENCE ON CURRENT AND FUTURE TRENDS OF INFORMATION AND COMMUNICATION TECHNOLOGIES IN HEALTHCARE (ICTH-2018). 141:255-262.

Piroth L, Launay O, Michel M-L, Bourredjem A, Miailhes P, Ajana F, Chirouze C, Zucman D, Wendling M-J, Nazzal D et al..  2016.  Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study. JOURNAL OF INFECTIOUS DISEASES. 213:1735-1742.

Pierron A, Bozon F, Berceanu A, Fontan J, Brion A, Deconinck E, Chirouze C, Brunel A-S.  2021.  Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination? VACCINE. 39:7036-7043.

Kayembe-Ntumba H-C, Vangola F, Ansobi P, Kapour G, Bokabo E, Mandja B-A, Bompangue D.  2022.  Vaccination dropout rates among children aged 12-23 months in Democratic Republic of the Congo: a cross-sectional study. ARCHIVES OF PUBLIC HEALTH. 80:18.

Ecarnot F, Maggi S, Michel J-P.  2020.  Vaccination (Prophylaxis) in the Elderly. ENCYCLOPEDIA OF BIOMEDICAL GERONTOLOGY, VOL 3. :401-411.

Lopez A, Mariette X, Bachelez H, Belot A, Bonnotte B, Hachulla E, Lahfa M, Lortholary O, Loulergue P, Paul S et al..  2017.  Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. JOURNAL OF AUTOIMMUNITY. 80:10-27.

Vignaud L-H.  2020.  Vaccinations. The myth of refusal. CANADIAN BULLETIN OF MEDICAL HISTORY. 37:313-316.